Современные возможности эндоскопической диагностики немышечно-инвазивного рака мочевого пузыря

В последние годы отмечается устойчивый рост заболеваемости раком мочевого пузыря (РМП) в нашей стране. Так, за последние 10 лет отмечается увеличение количества случаев первичной диагностики РМП более чем в 1,5 раза, что соответствует 77,1 случая на 100 тыс. населения. При этом летальность на первом году за тот же временной интервал снизилась с 22,4% в 2008 г. до 14,4% в 2019 г. У 75% пациентов данное заболевание диагностируется на ранней стадии (опухоль распространяется до мышечного слоя — немышечно-инвазивные формы РМП), что позволяет проводить органосохранное лечение. Одним из факторов, влияющих на данные показатели, является внедрение новых методов диагностического поиска в рутинную практику врачей. К таким методам относятся: фотодинамическая и узкоспектровая диагностика при выполнении цистоскопии, а также другие методы повышения визуализации скрытых опухолей.

1. Состояние онкологической помощи населению России в 2018 году под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой, 2019.

2. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual, 8th ed. Springer International Publishing: New York; 2017. Available from: https://www.springer.com/gp/book/9783319406176

3. Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) — 2019 Update. Eur Urol. 2019 Nov; 76(5): 639–657. https://doi.org/10.1016/j.eururo.2019.08.016

4. Алексеев Б. Я., Андронов А. С., Атдуев В. А., Байков Н. А., Важенин А. В., Васильев О.Н. и др. Рак мочевого пузыря (классика и новации). Медфорум. Монография. Москва, 2017, 262 с.

5. Иванов С.А., Заборский И.Н., Чайков В.С. Лечение немышечно-инвазивного рака мочевого пузыря высокого риска. Вестник Урологии. 2017; 5(2): 42–49. https://doi.org/10.21886/2308–6424–2017–5-2–42–49

6. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2017; 71(3): 447–461. https://doi.org/10.1016/j.eururo.2016.05.041

7. Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors-results of a prospective, randomized comparison to the standard approach. Urology. 2012 Apr; 79(4): 846–851. https://doi.org/10.1016/j.urology.2011.08.081

8. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, et al. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10): 589–596. https://doi.org/10.1038/nrurol.2014.245

9. Malmström P‐U, Agrawal S, Bläckberg M, Boström PJ, Malavaud B, Zaak D, et al. Non-muscle-invasive bladder cancer: a vision for the future. Scand J Urol. 2017 Apr; 51(2): 87–94. https://doi.org/10.1080/21681805.2017.1283359

10. Isfoss BL. The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard. BJU Int. 2011 Dec; 108(11): 1703–1707. https://doi.org/10.1111/j.1464–410X.2011.10485.x

11. Лоран О.Б., Серегин А.В., Дадашев Э.О., Бабаев А.Б., Лощенов В.Б. Фотодинамическая диагностика отечественной флуоресцентной видеосистемой неинвазивного рака мочевого пузыря. Consilium Medicum. 2018; 20(7): 37–40. https://doi.org/10.26442/2075–1753_2018.7.37–40

12. Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013 Nov; 64(5): 846–854. https://doi.org/10.1016/j.eururo.2013.03.059

13. Kamat A, Cookson M, Witjes JA, Stenzl A, Grossman HB. TheImpact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer — A New Analysis. Bladder Cancer. 2016 Apr 27; 2(2): 273–278. https://doi.org/10.3233/BLC-160048

14. Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, et al. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol. 2018; 36(8): 361.e1–361.e6. https://doi.org/10.1016/j.urolonc.2018.04.013

15. Gallagher KM, Gray K, Anderson CH, Lee H, Stewart S, Donat R, et al. “Real-life experience”: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study. World J Urol. 2017 Dec; 35(12): 1871–1877. https:// doi.org/10.1007/s00345–017–2077–6

16. Bach T, Bastian PJ, Blana A, Kaminsky A, Keller S, Knoll T, et al. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III. World J Urol. 2017 May; 35(5): 737–744. https://doi.org/10.1007/s00345–016–1925–0

17. Pagliarulo V, Alba S, Gallone MF, Di Stasi S, Cormio L, Petitti T, et al. Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy. J Endourol. 2017; 31(4): 405–411. https://doi.org/10.1089/end.2016.0804

18. Drăgoescu PO, Tudorache Ş, Drocaş AI, Mitroi G, Pănuş A, Drăgoescu NAM, et al. Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis. Rom J Morphol Embryol. 2017; 58(4): 1279–1283.

19. Lykke MR, Nielsen TK, Ebbensgaard NA, Zieger K. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis. Scand J Urol. 2015 Jun; 49(3): 230–236. https://doi.org/10.3109/21681805.2015.1019562

20. Kata SG, Zreik A, Ahmad S, Chłosta P, Aboumarzouk O. Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy? Cent European J Urol. 2016; 69(4): 334–340. https://doi.org/10.5173/ceju.2016.896

21. Kim SB, Yoon SG, Tae J, Kim JY, Shim JS, Kang SG, et al. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy. Investig Clin Urol. 2018; 59(2): 98–105. https://doi.org/10.4111/icu.2018.59.2.98

22. Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, et al. Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa 8 Study. Urology. 2017; 102: 138–142. https://doi.org/10.1016/j.urology.2016.11.032

23. Naito S, Algaba F, Babjuk M, Bryan RT, Sun Y H, Valiquette L, et al. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1 year Results. Eur Urol. 2016; 70(3): 506–515. https://doi.org/10.1016/j.eururo.2016.03.053

24. Xiong Y, Li J, Ma S, Ge J, Zhou L, Li D, et al. A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer. PLoS ONE. 2017; 12(2): e0170819. https://doi.org/10.1371/journal.pone.0170819

25. Bryan RT, Shah ZH, Collins SI, Wallace DMA. Narrow-bandimaging flexible cystoscopy: a new user’s experience. J Endourol. 2010 Aug; 24(8): 1339–1343. https://doi.org/10.1089/end.2009.0598

26. Kang W, Cui Z, Chen Q, Zhang D, Zhang H, Jin X. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis. Oncotarget. 2017 Apr 4; 8(14): 23880. https://doi.org/10.18632/oncotarget.13054

27. Geavlete BF, Brînzea A, ChecheriŢă IA, Zurac SA, GeorgescuDA, Bastian AE, et al. Carcinoma in situ of the urinary bladder — from pathology to narrow band imaging. Rom J Morphol Embryol. 2015; 56(3): 1069–1076.

28. Lee JY, Cho KS, Kang DH, Jung HD, Kwon JK, Oh CK, et al. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5 aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer. 2015 Aug 1; 15: 566. https://doi.org/10.1186/s12885–015–1571–8

29. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991 Nov 22; 254(5035): 1178–1181. https://doi.org/10.1126/science.1957169

30. Huang J, Ma X, Zhang L, Jia H, Wang F. Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis. Mol Clin Oncol. 2018 Apr; 8(4): 609–612. https://doi.org/10.3892/mco.2018.1566

31. Xiong YQ, Tan J, Liu Y M, Li Y Z, You F F, Zhang M Y, et al. Diagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2019 Sep; 27: 298–304. https://doi.org/10.1016/j.pdpdt.2019.06.006

32. Lerner SP, Goh A. Novel endoscopic diagnosis for bladder cancer. Cancer. 2015 Jan 15; 121(2): 169–178. https://doi.org/10.1002/cncr.28905

33. Chang TC, Liu J J, Hsiao ST, Pan Y, Mach KE, Leppert JT, et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol. 2013 May; 27(5): 598–603. https://doi.org/10.1089/end.2012.0549

34. Liem EI, Freund JE, Baard J, de Bruin DM, Laguna Pes MP, Savci-Heijink CD, et al. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. JMIR Res Protoc. 2018 Feb 7; 7(2): e34. https://doi.org/10.2196/resprot.8862

35. Rao AR, Hanchanale V, Javle P, Karim O, Motiwala H. Spectroscopic view of life and work of the Nobel Laureate Sir C.V. Raman. J Endourol. 2007 Jan; 21(1): 8–11. https://doi.org/10.1089/end.2006.9998

36. Schäfauer C, Ettori D, Rouprêt M, Phé V, Tualle J M, Tinet E, et al. Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. J Urol. 2013 Jul; 190(1): 271–277. https://doi.org/10.1016/j.juro.2013.01.100

37. Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. 2003 Nov; 21(11): 1369–1377. https://doi.org/10.1038/nbt899

38. Jain M, Robinson BD, Scherr DS, Sterling J, Lee M–M, Wysock J, et al. Multiphoton microscopy in the evaluation of human bladder biopsies. Arch Pathol Lab Med. 2012 May; 136(5): 517–526. https://doi.org/10.5858/arpa.2011–0147-OA

39. Tewari AK, Shevchuk MM, Sterling J, Grover S, Herman M, Yadav R, et al. Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery. BJU Int. 2011 Nov; 108(9): 1421–1429. https://doi.org/10.1111/j.1464–410X.2011.10169.x

40. Rivera DR, Brown CM, Ouzounov DG, Pavlova I, Kobat D, Webb WW, et al. Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue. Proc Natl Acad Sci USA. 2011 Oct 25; 108(43): 17598–17603. https://doi.org/10.1073/pnas.1114746108

41. Seibel EJ, Brentnall TA, Dominitz JA. New endoscopic and cytologic tools for cancer surveillance in the digestive tract. Gastrointest Endosc Clin N Am. 2009 Apr; 19(2): 299–307. https://doi.org/10.1016/j.giec.2009.02.002

42. Seibel EJ, Brown CM, Dominitz JA, Kimmey MB. Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies. Gastrointest Endosc Clin N Am. 2008 Jul; 18(3): 467–478, viii. https://doi.org/10.1016/j.giec.2008.05.001

43. Yoon WJ, Park S, Reinhall PG, Seibel EJ. Development of an Automated Steering Mechanism for Bladder Urothelium Surveillance. J Med Device. 2009 Mar 1; 3(1): 11004. https://doi.org/10.1115/1.3054381